Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001244125 | SCV001417325 | uncertain significance | Deficiency of galactokinase | 2022-06-04 | criteria provided, single submitter | clinical testing | This sequence change replaces serine, which is neutral and polar, with glycine, which is neutral and non-polar, at codon 310 of the GALK1 protein (p.Ser310Gly). This variant is present in population databases (rs201681295, gnomAD 0.03%). This variant has not been reported in the literature in individuals affected with GALK1-related conditions. ClinVar contains an entry for this variant (Variation ID: 968887). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Natera, |
RCV001244125 | SCV002088891 | uncertain significance | Deficiency of galactokinase | 2021-10-14 | no assertion criteria provided | clinical testing |